Effects of DDAVP and venous occlusion on the release of tissue-type plasminogen activator and von Willebrand factor in patients with panhypopituitarism.
D001127:Arginine Vasopressin / Q000494:pharmacology*; D001779:Blood Coagulation Factors / Q000096:biosynthesis*; D003250:Constriction; D003894:Deamino Arginine Vasopressin / Q000494:pharmacology*; D004727:Endothelium / Q000502:physiology; D006801:Humans; D007016:Hypophysectomy; D007018:Hypopituitarism / Q000503:physiopathology*; D010960:Plasminogen Activators / Q000378:metabolism*; D014680:Veins / Q000502:physiology; D014841:von Willebrand Factor / Q000096:biosynthesis*
D001779:Blood Coagulation Factors; D014841:von Willebrand Factor; D001127:Arginine Vasopressin; D010960:Plasminogen Activators; D003894:Deamino Arginine Vasopressin